Context Therapeutics and Integral Molecular Enter Collaboration and License Deal for Novel Claudin 6 Antibodies for Gynecologic Cancer Therapeutic Program
PHILADELPHIA, April 08, 2021 (GLOBE NEWSWIRE) — Context Therapeutics, a clinical-stage women’s oncology company developing…
Unitree Robotics IPO Sets the Stage: Shoucheng Holdings’ (00697.HK) Robotics Portfolio Value Comes Into Focus
The Executive Centre to Open Premium Workspace at 400 George, Expanding its Sydney CBD Footprint
OMP Launches Unison Express to Fast-Track Supply Chain Planning from Ambition to Early Value
Unitree Robotics IPO Nears Listing Committee Review; Shoucheng Holdings (697.HK), with a 3.8% Stake, Opens a Revaluation Window for Its Robotics Assets
Kingsoft Announces 2026 First Quarter Results